Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
17M
-
Shares change
-
+1.5M
-
Total reported value, excl. options
-
$89M
-
Value change
-
+$8.08M
-
Put/Call ratio
-
0
-
Number of buys
-
27
-
Number of sells
-
-34
-
Price
-
$5.25
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q1 2019
84 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q1 2019.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17M shares
of 86.6M outstanding shares and own 19.59% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.32M shares), MPM ASSET MANAGEMENT LLC (2.17M shares), BVF INC/IL (1.99M shares), 683 Capital Management, LLC (1.6M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.55M shares), BlackRock Inc. (1.5M shares), VANGUARD GROUP INC (948K shares), DIMENSIONAL FUND ADVISORS LP (908K shares), RENAISSANCE TECHNOLOGIES LLC (315K shares), and STATE STREET CORP (243K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.